Pulmatrix Inc (PULM): So $MYL's generic Advair got denied, for...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	52
Boards Moderated	0
Alias Born	03/23/2016

iambillytalent

Re: None

Wednesday, 03/29/2017 4:49:29 PM

Wednesday, March 29, 2017 4:49:29 PM

So $MYL's generic Advair got denied, for now. I'm assuming that's what triggered the BO rumor for $PULM. I do have a few questions:

$MYL only has control over PUR0200, right?

As for the iSperse tech, I'm assuming Pulmatrix can license out their tech to any one, right? If that's the case, I would assume Mylan would do their best to cut their losses with the generic Advair and purchase Pulmatrix as soon as possible.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent PULM News

Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:06:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 02:00:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 02:20:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 02:05:40 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 01:20:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 01:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 08:05:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 01:05:21 PM